Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000093751-26-000448
Filing Date
2026-08-07
Accepted
2026-08-07 09:20:57
Documents
1
X0202

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 6057
  Complete submission text file 0000093751-26-000448.txt   8153
Mailing Address 1 CONGRESS STREET SUITE 1 BOSTON MA 02114
Business Address 1 CONGRESS STREET SUITE 1 BOSTON MA 02114 617 786-3000
STATE STREET CORP (Filed by) CIK: 0000093751 (see all company filings)

EIN.: 042456637 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SCHEDULE 13G
SIC: 6022 State Commercial Banks
(CF Office: 02 Finance)

Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Subject) CIK: 0001501989 (see all company filings)

EIN.: 273521219 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-89140 | Film No.: 261251758
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)